Calnexin Induces Expansion of Antigen-Specific CD4+ T Cells that Confer Immunity to Fungal Ascomycetes via Conserved Epitopes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Fungal infections remain a threat due to the lack of broad spectrum fungal vaccines and protective antigens. Recent studies showed that attenuated Blastomyces dermatitidis confers protection via T cell recognition of an unknown, but conserved antigen. Using transgenic CD4+ T cells recognizing this antigen, we identify an amino acid determinant within the chaperone calnexin that is conserved across diverse fungal ascomycetes. Calnexin, typically an ER protein, also localizes to the surface of yeast, hyphae and spores. T cell epitope mapping unveiled a 13-residue sequence conserved across Ascomycota. Infection with divergent ascomycetes including dimorphic fungi, opportunistic molds, and the agent causing white nose syndrome in bats induces expansion of calnexin-specific CD4+ T cells. Vaccine delivery of calnexin in glucan particles induces fungal antigen-specific CD4+ T cell expansion and resistance to lethal challenge with multiple fungal pathogens. Thus, the immunogeneticity and conservation of calnexin make this fungal protein a promising vaccine target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828 · cited 1×
“Our findings are in line with data in humanswhereCandida-responsive, IL-17producing T cells persist (Acosta-Rodriguez et al., 2007).”
ResultFate mapping of IL-17-producing T cells in inflammatory responses
Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. (2011) · Nature Immunology · doi:10.1038/ni.1993 · Cited by 1,176
Hirota, K., Yoshitomi, H., Hashimoto, M., Maeda, S., Teradaira, S., Sugimoto, N., Yamaguchi, T., Nomura, T., Ito, H., Nakamura, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071397 · Cited by 937 · cited 1×
“After vaccination with calnexin, 15%–20% of the tetramer-positive cells in the draining lymph nodes display the chemokine receptors CCR6 or CXCR3 (Figure S5B), which are linked with, respectively, Th17 and Th1 cell recruitment (Hirota et al., 2007; Nanjappa et al., 2012a, 2012b).”
BackgroundA novel glyco-conjugate vaccine against fungal pathogens
Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050749 · Cited by 442
Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-10 · Cited by 238 · cited 1×
“Candida is now among the leading agents of nosocomial bloodstream infections (Pfaller et al., 2011).”
BackgroundAntibodies to a cell surface histone-like protein protect against Histoplasma capsulatum
Nosanchuk, J. D., Steenbergen, J. N., Shi, L., Deepe, G. S., & Casadevall, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19361 · Cited by 178 · cited 1×
“Likewise, histone-like proteins have been detected on the surface of this fungus, and antibodies directed against these proteins confer immunity (Nosanchuk et al., 2003).”
BackgroundSelf-citationGeneration of highly purified and functionally active human TH1 cells against Aspergillus fumigatus
Beck, O., Topp, M. S., Koehl, U., Roilides, E., Simitsopoulou, M., Hanisch, M., Sarfati, J., Latgé, J. P., Klingebiel, T., Einsele, H., et al. (2006) · Blood · doi:10.1182/blood-2005-04-1660 · Cited by 127 · cited 2×
“…fungal surface, and because the fungus induces expansion of calnexin-specific CD4+ T cells during infection, transfer of calnexin-specific T cells that are activated, expanded, and enriched in vitro may offer immunotherapeutic benefit to patients with invasive fungal infection (Beck et al., 2006).”
Cited by
Immune responses to human fungal pathogens and therapeutic prospects
Lionakis, M. S., Drummond, R. A., & Hohl, T. M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00826-w · Cited by 379
Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts
Lionakis, M. S., & Levitz, S. M. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053318 · Cited by 209
Lionakis, M. S., Iliev, I. D., & Hohl, T. M. (2017) · JCI Insight · doi:10.1172/jci.insight.93156 · Cited by 153
Vaccines for human fungal diseases: close but still a long way to go
Oliveira, L. V. N., Wang, R., Specht, C. A., & Levitz, S. M. (2021) · npj Vaccines · doi:10.1038/s41541-021-00294-8 · Cited by 135
Metadata
- Authors
- Wüthrich, M., Brandhorst, T. T., Sullivan, T. D., Filutowicz, H., Sterkel, A., Stewart, D., Li, M., Lerksuthirat, T., LeBert, V., Shen, Z. T., Ostroff, G., Deepe, G. S., Hung, C. Y., Cole, G., Walter, J. A., Jenkins, M. K., & Klein, B.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 17
- Issue
- 4
- Pages
- 452-465
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2125871798
- Cited by
- 69
- References
- 7
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calnexin Induces Expansion of Antigen-Specific CD4+ T Cells that Confer Immunity to Fungal Ascomycetes via Conserved Epitopes. https://app.cochat.ai/papers/10.1016/j.chom.2015.02.009
- The paper
- Wüthrich, M., Brandhorst, T. T., Sullivan, T. D., Filutowicz, H., Sterkel, A., Stewart, D., Li, M., Lerksuthirat, T., LeBert, V., Shen, Z. T., Ostroff, G., Deepe, G. S., Hung, C. Y., Cole, G., Walter, J. A., Jenkins, M. K., & Klein, B. (2015). Calnexin Induces Expansion of Antigen-Specific CD4+ T Cells that Confer Immunity to Fungal Ascomycetes via Conserved Epitopes. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2015.02.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.